🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Breast Carcinoma

Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary Surgery NCT07140172NA55 sites📍 Bethesda📍 Durham📍 Philadelphia University Hospital, Basel, Switzerland · Tests: Axillary lymph node dissection (ALND), Axillary radiotherapy (ART) Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor NCT05933395Phase 21 site📍 Lebanon Dartmouth-Hitchcock Medical Center · Tests: Fulvestrant, Neratinib, Alpelisib, Everolimus, Abemaciclib Elacestrant in Patients With ER+ HER2- ESR1-mutated Locally Advanced or Metastatic Breast Cancer NCT07563595n/a3 sites📍 Freiburg im Breisgau📍 Paderborn📍 Ravensburg iOMEDICO AG · Tests: Elacestrant, Standard of care (Investigator Choice) Breast Cancer Survivorship Biorepository NCT05786664n/a1 site📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Electronic Health Record Review, Quality-of-Life Assessment, Survey Administration Use of Magtrace Bracketing for Excision of Lesion and Sentinel Lymph Node Localization in Breast Conserving Surgery for Breast Cancer NCT07844473NA1 site📍 Madinah King Faisal Specialist Hospital & Research Center · Tests: Super paramagnetic iron oxide bracketing injection AI-Assisted Chemotherapy Side Effect Management NCT07198581NA1 site📍 Incheon Incheon St.Mary's Hospital · Tests: LLM-assisted chemotherapy side effect management Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype NCT07341867Phase 11 site📍 Boston Andrew Hantel, MD · Tests: Dexamethasone, Bortezomib, LENALIDOMIDE, Daratumumab, Carboplatin An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors NCT07222267Phase 132 sites📍 Birmingham📍 New Haven📍 St Louis BeOne Medicines · Tests: BG-75202, CDK4 Inhibitor, Estrogen Receptor Antagonist, Aromatase Inhibitor To Evaluate the Clinical Efficacy of Probiotics in Patients With the Breast Cancer NCT06039644NA1 site📍 Taipei GenMont Biotech Incorporation · Tests: Probiotic, Placebo Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors NCT04557449Phase 1, Phase 239 sites📍 Los Angeles📍 New Haven📍 New Haven Pfizer · Tests: PF-07220060, Letrozole, Fulvestrant, Midazolam, Enzalutamide CtDNA Based MRD Testing for NAC Monitoring in TNBC NCT06230185n/a14 sites📍 Tucson📍 Aurora📍 Washington D.C. Personalis Inc. The Development of MASLD Among Survivors of Breast or Colorectal Cancer NCT07280143n/a1 site📍 Bern University of Bern Examining and Comparing the Temporal Changes and Results of Cosmetic, Quality of Life and Patient Satisfaction Achieved With Immediate and Delayed-immediate Implant-based Breast Reconstruction Procedures and Contralateral Symmetrization Techniques NCT04356235n/a1 site📍 Budapest National Institute of Oncology, Hungary · Tests: A: expander-silicone implant exchange and contralateral symmetrization with mastopexy and if needed with volume reducti… Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer NCT04913064NA1 site📍 Duarte City of Hope Medical Center · Tests: Questionnaire Administration, White Button Mushroom Extract All-extremity Exercise During Breast Cancer Chemotherapy NCT04914663NA1 site📍 Gainesville University of Florida · Tests: Exercise training Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer. NCT05378204NA25 sites📍 Bordeaux📍 Caen📍 Clermont-Ferrand Institut Claudius Regaud · Tests: Main study:, Sub-study: Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy NCT07386444NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Inspiratory muscle training Development of Clinical and Biological Database NCT03449264NA1 site📍 Montpellier Institut du Cancer de Montpellier - Val d'Aurelle · Tests: biological collection Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes. NCT04019678NA1 site📍 Rozzano Istituto Clinico Humanitas · Tests: Omission of Axillary dissection A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors NCT06609187Phase 11 site📍 Beijing Sichuan Baili Pharmaceutical Co., Ltd. · Tests: GNC-077 Validation of the Oncoliq Test for the Early Detection of Breast Cancer. NCT07331506n/a1 site📍 Buenos Aires Oncoliq US Inc · Tests: Peripheral blood draw RESET-BRAIN: REhabilitation of SleEp and CogniTive Impairment in BReast Cancer Survivors Using an App-based Intervention NCT06553235NA1 site📍 Aarhus N Aarhus University Hospital · Tests: Cognitive Behavioral Therapy for Insomnia (CBT-I), Sleep hygiene education Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors NCT06729684NA1 site📍 Seoul Samsung Medical Center · Tests: digital health (application and smartwatch) MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles NCT03053193n/a134 sites📍 Birmingham📍 Anchorage📍 Phoenix Agendia · Tests: MammaPrint, BluePrint, and Full-Genome Testing Application of 68GA-labeled CD73 Targeting Probe PET/CT Imaging in the Diagnosis of Breast Cancer NCT06411678EARLY Phase 11 site📍 Dongcheng Peking Union Medical College Hospital · Tests: 68GA-DOTA-dPNE The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast Cancer NCT04291378NA8 sites📍 Aalborg📍 Aarhus📍 Copenhagen Danish Breast Cancer Cooperative Group · Tests: Proton versus photon radiation therapy Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer NCT06105684Phase 21 site📍 Birmingham University of Alabama at Birmingham · Tests: Capecitabine Pill Evaluating the Effectiveness of Aromatherapy for Alleviating Distress in Breast Cancer Patients Before Radiotherapy. NCT06766058NA1 site📍 Singapore National Cancer Centre, Singapore · Tests: Carrier oil, Asian plant extract blend Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction NCT04342546NA9 sites📍 Dijon📍 Lille📍 Lyon Institut du Cancer de Montpellier - Val d'Aurelle · Tests: NovaGray RILA Breast® test Comparison of Postoperative Analgesic Efficacy of Two Different Blocks in Modified Radical Mastectomy Surgery NCT07737132NA1 site📍 Istanbul Sultan Abdulhamid Han Training and Research Hospital, Istan… · Tests: Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block (SPSIPB), Ultrasound-Guided Serratus Anterior Pla…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy